Literature DB >> 14713255

Highlights of the biology of endocrine tumours of the gut and pancreas.

G Rindi1, C Bordi.   

Abstract

Originating from cells of the diffuse endocrine system the endocrine tumours of the gut and the pancreatic tract are rare entities characterized by a common phenotypic aspect and producing several bioactive substances including growth factors. Two major categories are identified: well-differentiated and poorly differentiated tumours. The clinical behaviour varies ranging from benign to low grade malignant for well-differentiated tumours/carcinomas to high grade malignant for poorly differentiated carcinomas. The two major categories of well-differentiated and poorly differentiated tumours display distinct phenotypes and genetic backgrounds possibly supporting distinct histogenesis. Genetic abnormalities associated with either induction or progression of tumours may vary depending on the site of origin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14713255     DOI: 10.1677/erc.0.0100427

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  7 in total

Review 1.  Pathologic pancreatic endocrine cell hyperplasia.

Authors:  Debra Ouyang; Deepti Dhall; Run Yu
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

2.  Expression of estrogen-induced genes and estrogen receptor β in pancreatic neuroendocrine tumors: implications for targeted therapy.

Authors:  Jeannelyn S Estrella; Ly T Ma; Denái R Milton; James C Yao; Huamin Wang; Asif Rashid; Russell R Broaddus
Journal:  Pancreas       Date:  2014-10       Impact factor: 3.327

3.  IL-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs).

Authors:  Maja Cigrovski Berković; Mladen Jokić; Jasminka Marout; Senka Radosević; Vanja Zjacić-Rotkvić; Sanja Kapitanović
Journal:  J Mol Med (Berl)       Date:  2010-01-05       Impact factor: 4.599

4.  Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy.

Authors:  Liesbeth M Veenendaal; Inne H M Borel Rinkes; Cornelis J M Lips; Richard van Hillegersberg
Journal:  World J Surg Oncol       Date:  2006-06-26       Impact factor: 2.754

5.  The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract.

Authors:  V Formica; A Wotherspoon; D Cunningham; A R Norman; B Sirohi; J Oates; G Chong
Journal:  Br J Cancer       Date:  2007-04-03       Impact factor: 7.640

Review 6.  Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment.

Authors:  Cynthia Ro; Wanxing Chai; Victoria E Yu; Run Yu
Journal:  Chin J Cancer       Date:  2012-12-14

7.  Endocrine tumors of the gastrointestinal tract and pancreas: grading, tumor size and proliferation index do not predict malignant behavior.

Authors:  Borislav A Alexiev; Cinthia B Drachenberg; John C Papadimitriou
Journal:  Diagn Pathol       Date:  2007-08-08       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.